Global Extended-Release Drugs Market to Reach $88.22 Billion by 2027: A Comprehensive Analysis

LANDON, GREATER LANDON, UK, October 24, 2023 /EINPresswire.com/ -- The global extended-release drugs market is anticipated to witness substantial growth in the coming years, with projections indicating a surge to $88.22 billion by 2027 at a Compound Annual Growth Rate (CAGR) of 11.5%. This expansion is primarily attributed to the escalating prevalence of chronic conditions, necessitating the development of advanced drug delivery systems to cater to the growing medical needs.

Rising Incidence of Chronic Conditions Driving Market Growth

The market's growth is propelled by the increasing incidence of chronic diseases, including heart disease, cancer, obesity, and diabetes. These complex health issues require a continuous and stable release of medications, making extended-release drug delivery systems crucial for maintaining consistent therapeutic effects and minimizing fluctuations in drug levels.

Product Innovation and Technological Advancements Spearheading Market Advancement

Key players like Pfizer Inc., Novartis AG, and Gilead Sciences Inc. are focusing on innovative product development to sustain their market position. Recent advancements include Zydus Pharmaceuticals (USA) Inc.'s launch of Topiramate extended-release capsules for epilepsy, demonstrating the sector's commitment to catering to specific medical needs through cutting-edge pharmaceutical solutions.

Check out this sample link for a closer look at the latest trends and developments in the extended-release drugs market:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12675&type=smp

Strategic Acquisitions Shaping Market Landscape

Strategic acquisitions also play a vital role in shaping the extended-release drugs market. Pfizer Inc.'s acquisition of Arena Pharmaceuticals for $6.7 billion illustrates the company's dedication to diversifying its pharmaceutical portfolio and investing in promising development-stage pharmaceutical prospects in various therapeutic fields.

Market Segments And Regional Outlook

The global extended-release drugs market is segmented -
1. By Type: Sustained Release Drug, Controlled Release Drug
2. By Mode: Over-The-Counter, Prescription
3. By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores

The extended-release drugs market is poised for significant growth, with North America leading the way and Asia-Pacific projected to be the fastest-growing region. For comprehensive insights into this dynamic market, explore the sample report, and stay updated with the latest developments.

Gain access to a detailed analysis of the global extended-release drugs market by exploring the comprehensive report:
https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report

Extended Release Drugs Global Market Report 2023 from TBRC covers the following information:

1. Market size date for the forecast period: Historical and Future
2. Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
3. Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Extended Release Drugs Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on extended release drugs market size, extended release drugs market drivers and trends, extended release drugs market major players, competitors' revenues, extended release drugs market positioning, and extended release drugs market growth across geographies. The extended release drugs market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Implantable Drug Delivery Devices Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Drug Device Combination Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/drug-device-combination-global-market-report

Injectable Drug Delivery Devices Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn